Truist Securities analyst David MacDonald reiterated a Buy rating and $620.00 price target on Elevance (NYSE: ELV).The analyst comments "First ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Elevance (ELV) PT Raised to $585 at RBC CapitalJuly 18, 2024 6:13 AM Morgan Stanley Reiterates Overweight Rating on Elevance (ELV)July 17, 2024 8:28 AM Form 8-K Elevance Health, Inc. For: Jul 17July 17, 2024 6:10 AM Elevance Health Inc. (ELV) Tops Q2 EPS by 11cJuly 17, 2024 6:03 AM Elevance Health Reports Second Quarter 2024 ResultsJuly 17, 2024 6:00 AM TD Cowen Reiterates Buy Rating on Elevance (ELV)July 16, 2024 7:19 AM Elevance (ELV) PT Raised to $620 at Truist SecuritiesJuly 15, 2024 7:15 AM